Risk factors for poor virological outcome at 12 months in a workplace-based antiretroviral therapy programme in South Africa: A cohort study
Open Access
- 16 July 2008
- journal article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 8 (1) , 93
Abstract
Reasons for the variation in reported treatment outcomes from antiretroviral therapy (ART) programmes in developing countries are not clearly defined.Keywords
This publication has 27 references indexed in Scilit:
- Patient Retention in Antiretroviral Therapy Programs in Sub-Saharan Africa: A Systematic ReviewPLOS Medicine, 2007
- Evaluation of a workplace HIV treatment programme in South AfricaAIDS, 2007
- Establishing a workplace antiretroviral therapy programme in South AfricaAIDS Care, 2007
- Antiretroviral Therapy in a Thousand Patients with AIDS in HaitiNew England Journal of Medicine, 2005
- Promoting adherence to antiretroviral therapyAIDS, 2004
- Virologic and immunologic outcomes and programmatic challenges of an antiretroviral treatment pilot project in Abidjan, Côte dʼIvoireAIDS, 2003
- Antiretroviral therapy in the private sector of Nairobi, KenyaAIDS, 2003
- Impact of Adherence and Highly Active Antiretroviral Therapy on Survival in HIV-Infected PatientsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2002
- Initial Virological and Immunologic Response to Highly Active Antiretroviral Therapy Predicts Long‐Term Clinical OutcomeClinical Infectious Diseases, 2001
- Virologic Outcome and Predictors of Virologic Failure of Highly Active Antiretroviral Therapy Containing Protease InhibitorsAIDS Patient Care and STDs, 2001